Press Releases

02.18.2016
Ophthotech Corporation to Present at RBC Capital Markets Healthcare Conference
02.17.2016
Ophthotech Corporation to Report Fourth Quarter 2015 Financial Results and Host Conference Call on Wednesday, February 24, 2016
02.03.2016
Ophthotech Corporation to Present at the LEERINK Partners 5th Annual Global Healthcare Conference
01.27.2016
Ophthotech Announces First Patient Dosed in Zimura® Phase 2/3 Study to Evaluate Treatment in Patients with Geographic Atrophy, an Advanced Form of Dry Age-Related Macular Degeneration
01.06.2016
Ophthotech Announces Appointment of David E. Redlick to Its Board of Directors
01.05.2016
Glenn P. Sblendorio to Join Ophthotech as Executive Vice President, Chief Operating Officer and Chief Financial Officer
01.04.2016
Ophthotech Corporation to Present at the 34th Annual J.P. Morgan Healthcare Conference
12.02.2015
Ophthotech Corporation to Present at the Oppenheimer 26th Annual Healthcare Conference
12.01.2015
Ophthotech Corporation to Host R&D Investor Day on December 3, 2015
11.17.2015
Ophthotech Announces that Genentech, a Roche Wholly-Owned Subsidiary, Elects to Exercise Its Right to Opt-in to the Novartis Portion of the Ophthotech / Novartis Ex-US Agreement for Fovista® to Treat Wet Age-Related Macular Degeneration